Effects of Corticotropin-Releasing Hormone Receptor 1 (CRH1) Antagonism on Stress-Induced Craving in Alcoholic Women With High Anxiety: an Experimental Medicine Study
Phase of Trial: Phase II
Latest Information Update: 10 Nov 2016
Price : $35 *
At a glance
- Drugs Verucerfont (Primary)
- Indications Alcoholism
- Focus Therapeutic Use
- 31 Aug 2018 Biomarkers information updated
- 14 Sep 2015 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 30 Dec 2014 Planned End Date changed from 1 Jan 2015 to 1 Jun 2016 as reported by ClinicalTrials.gov record .